Tech Center 3700 • Art Units: 2484 2488 2872 2873 3781
This examiner grants 86% of resolved cases
Tuyen Q Tra is an examiner in Tech Center 3700, Art Unit 2484. The examiner has 1029 resolved cases. The data shows an allowance rate of 85.6 percent and an interview lift of 9.2 percent. The median days to allowance for these cases is 840.
The 9.2 percent interview lift is a metric that can be compared to the 85.6 percent base allowance rate. This indicates that conducting an interview is a method for increasing the likelihood of an allowance. The 840 day median pendency is the timeframe applicants can expect when navigating the resolved cases handled by this examiner in Art Unit 2484. Practitioners can consider how these metrics influence the overall prosecution timeline.
With 1029 resolved cases, the examiner's statistics provide a view of the prosecution landscape. Practitioners can use the 85.6 percent allowance rate to assess the probability of a grant. The 9.2 percent lift and the Tech Center 3700 environment are factors for prosecution strategy. These data points help in setting expectations for clients.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18875236 | OPTICAL SYSTEM FOR A VEHICLE COMPRISING A CAMERA | Non-Final OA | VALEO VISION |
| 18863981 | LENS UNIT | Non-Final OA | DAICEL CORPORATION |
| 18917211 | CONTINUOUS PHOTOLITHOGRAPHIC FABRICATION PROCESS FOR PRODUCING SEAMLESS MICROSTRUCTURES USED IN ELECTRO-OPTIC DISPLAYS AND LIGHT MODULATING FILMS | Non-Final OA | E INK CORPORATION |
| 18681070 | HEATER, LENS UNIT, CAMERA MODULE, IN-VEHICLE SYSTEM, MOBILE BODY, AND HEATER INCORPORATION METHOD | Non-Final OA | Maxell, Ltd. |
| 18881958 | RETINAL IMAGING SYSTEM AND RETINAL IMAGING ADAPTOR AND RELATED METHODS OF USE | Non-Final OA | Verily Life Sciences LLC |
| 17719413 | SYSTEM AND METHOD FOR GENERATING A THREE-DIMENSIONAL (3D) EYEGLASSES MODEL | Non-Final OA | META PLATFORMS, INC. |
| 18708810 | INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND COMPUTER PROGRAM | Non-Final OA | MITSUI CHEMICALS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy